Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Veronesi G, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G; European Group on Graves' Orbitopathy. Bartalena L, et al. Among authors: marcocci c. J Clin Endocrinol Metab. 2012 Dec;97(12):4454-63. doi: 10.1210/jc.2012-2389. Epub 2012 Oct 4. J Clin Endocrinol Metab. 2012. PMID: 23038682 Clinical Trial.
Treating severe Graves' ophthalmopathy.
Bartalena L, Marcocci C, Pinchera A. Bartalena L, et al. Among authors: marcocci c. Baillieres Clin Endocrinol Metab. 1997 Oct;11(3):521-36. doi: 10.1016/s0950-351x(97)80738-0. Baillieres Clin Endocrinol Metab. 1997. PMID: 9532337 Review.
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
Bartalena L, Veronesi G, Krassas GE, Wiersinga WM, Marcocci C, Marinò M, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G, Perros P, Kahaly GJ; European Group on Graves’ Orbitopathy (EUGOGO). Bartalena L, et al. Among authors: marcocci c. J Endocrinol Invest. 2017 May;40(5):547-553. doi: 10.1007/s40618-017-0608-z. Epub 2017 Feb 7. J Endocrinol Invest. 2017. PMID: 28176220
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.
Perros P, Žarković MP, Panagiotou GC, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi AM, Nardi M, Brix TH, Covelli D, Daumerie C, Eckstein AK, Fichter N, Ćirić S, Hegedüs L, Kahaly GJ, Konuk O, Lareida JJ, Okosieme OE, Leo M, Mathiopoulou L, Clarke L, Menconi F, Morris DS, Orgiazzi J, Pitz S, Salvi M, Muller I, Knežević M, Wiersinga WM, Currò N, Dayan CM, Marcocci C, Marinò M, Möller L, Pearce SH, Törüner F, Bernard M; European Group on Graves’ Orbitopathy. Perros P, et al. Among authors: marcocci c. J Endocrinol Invest. 2020 Dec;43(12):1717-1722. doi: 10.1007/s40618-020-01258-w. Epub 2020 May 30. J Endocrinol Invest. 2020. PMID: 32474767 Free PMC article.
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
DeGroot LJ, Gorman CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel MF, Wartofsky L, Marocci C [corrected to Marcocci C]. DeGroot LJ, et al. Among authors: marcocci c. J Clin Endocrinol Metab. 1995 Feb;80(2):339-40. doi: 10.1210/jcem.80.2.7677823. J Clin Endocrinol Metab. 1995. PMID: 7677823 No abstract available.
Cigarette smoking and treatment outcomes in Graves ophthalmopathy.
Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A. Bartalena L, et al. Among authors: marcocci c. Ann Intern Med. 1998 Oct 15;129(8):632-5. doi: 10.7326/0003-4819-129-8-199810150-00010. Ann Intern Med. 1998. PMID: 9786811 Clinical Trial.
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Marcocci C, et al. J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7. doi: 10.1210/jcem.86.8.7737. J Clin Endocrinol Metab. 2001. PMID: 11502779 Clinical Trial.
An update on medical management of Graves' ophthalmopathy.
Bartalena L, Marcocci C, Tanda ML, Piantanida E, Lai A, Marinò M, Pinchera A. Bartalena L, et al. Among authors: marcocci c. J Endocrinol Invest. 2005 May;28(5):469-78. doi: 10.1007/BF03347230. J Endocrinol Invest. 2005. PMID: 16075933 Review.
406 results